3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
80
Stomach Neoplasms
64
Rectal Neoplasms
39
Pancreatic Neoplasms
31
Colonic Neoplasms
27
Esophageal Neoplasms
24
Lymphoma, Large B-Cell, Diffuse
20
Adenocarcinoma
19
Neoplasms
18
Cholangiocarcinoma
16
Neoplasm Metastasis
15
Adenocarcinoma Of Esophagus
14
Biliary Tract Neoplasms
12
Carcinoma, Non-Small-Cell Lung
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Ovarian Neoplasms
10
Gastrointestinal Neoplasms
7
Gallbladder Neoplasms
7
Carcinoma, Hepatocellular
7
Esophageal Squamous Cell Carcinoma
6
Endometrial Neoplasms
6
Locally Advanced Rectal Cancer
5
Recurrence
4
Lymphoma
4
Carcinoma
4
Bile Duct Neoplasms
4
Advanced Solid Tumors
4
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Peritoneal Neoplasms
3
Interventions
Cyclophosphamide
12
fludarabine phosphate
7
fludarabine
7
venetoclax
6
blinatumomab
6
Cytarabine
5
Lenalidomide
4
Dexamethasone
4
Blood Specimen Collection
4
Azacitidine
4
obinutuzumab
3
Rituximab
3
Radiotherapy
3
Melphalan
3
Immunotherapy, Adoptive
3
pembrolizumab
2
daratumumab
2
Neoadjuvant Therapy
2
Idarubicin
2
Chemotherapy, Adjuvant
2
Capecitabine
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
thymoglobulin
1
tetrathiomolybdate
1
talquetamab
1
tagraxofusp
1
sacituzumab govitecan
1
sabatolimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Oxaliplatin
×
1 year
×
Clear all
No trials found.